Albany,
New York, August 19, 2014 – In its latest report titled, ‘Organ
Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK,
Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA
Transplant Solution and Others, and By Preservation Techniques-
Hypothermic Perfusion Preservation, Static Cold Storage and Others) -
Global Industry Analysis, Size, Share, Growth, Trends and Forecast,
2013 – 2019’, Transparency Market Research states that in 2012,
the worldwide market for organ preservation solutions was worth $0.06
billion and will grow to $0.20 billion in 2019 at a CAGR of 16.5%.
To
browse through the ToC or purchase the organ preservation solutions
market report, please visit:
The
market is largely driven by the increasing number of patients on the
organ transplant list. Change in lifestyle such as alcohol
consumption, smoking and fast food have led to rising incidences of
organ failure, also giving rise to organ preservation solutions
especially in developed countries such as the U.S. and the U.K. Other
factors which have contributed to the growth of the industry include
widening geriatric population, technological advancements, improving
reimbursement conditions, and rise in per capita healthcare
expenditure in emerging economies such as India.
In
contrast, the lack of organ donors and high cost of preserving and
maintaining the organs has restrained the growth of the market.
The
market can be segmented on the basis of technique, solution and
geography. The various solutions for organ preservation, as mentioned
in the report, include Custodiol HTK
(Histidine-Tryptophan-Ketoglutarate), Viaspan, Renograf, Perfadex,
Hypothermosol, Lifor, siRNA Transplant Solutions, and Human bioSystem
(HBS) Solution. The different techniques used to preserve organs
include Static Cold Storage (SCS) and Hypothermic Perfusion
Preservation (HPP). The four main regions that the global organ
preservation solutions market is divided into are North America,
Europe, Asia-Pacific and Rest of the World.
Of
the major solutions, Custodial and Viaspan together account for more
than 75% of the total market share as far as revenue is concerned.
Custodial is expected to register a 17.1% CAGR during the forecast
period, making it the fastest growing segment among solutions. Among
techniques, the HPP segment is estimated to grow at a CAGR of 19.2%
from 2013 to 2019. Europe accounted for the largest share in the
total revenue in 2012, growing at a CAGR of 17.3% during the forecast
period.
The
global market for organ preservation solutions is led by players such
as Teva Pharmaceutical Industries Ltd., Dr. Franz Köhler Chemie
GmbH, BioLife Solutions, Inc., Bristol-Myers Squibb, ToleroTech,
Inc., and XVIVO Perfusion AB.
About
Us
We
are privileged with highly experienced team of Analysts, Researchers
and Consultants, who use proprietary data sources and various tools
and techniques to gather, and analyze information. Our business
offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact
Transparency
Market Research
90
State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA
- Canada Toll Free 866-552-3453
No comments:
Post a Comment